The National Institutes of Health (NIH) Scientific Workshop on Violence & Related Health Outcomes in Sexual & Gender Minority Communities Open Session, 40863-40864 [2021-16190]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 26, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16162 Filed 7–28–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The National Institutes of Health (NIH)
Scientific Workshop on Violence &
Related Health Outcomes in Sexual &
Gender Minority Communities Open
Session
AGENCY:
ACTION:
BILLING CODE 4140–01–P
National Institutes of Health,
HHS.
Notice.
The National Institutes of
Health (NIH) will hold the Phase IV
open session for the NIH Scientific
Workshop on Violence and Related
Health Outcomes in Sexual and Gender
Minority (SGM) Communities to
enhance our understanding of violence
against SGM individuals and identify
opportunities in violence-related
research. The primary objectives of
NIH’s Phase IV meeting are: (1) To allow
the public to participate, and (2) to
further refine research opportunities.
DATES: The NIH Scientific Workshop on
Violence and Related Health Outcomes
in Sexual and Gender Minority
Communities Phase IV virtual meeting
will be held on Thursday, August 26,
2021, from 12:00–4:00 p.m. Eastern
Daylight Time (New York, GMT).
ADDRESSES: The meeting will be held
virtually via WebEx.
The preliminary agenda and
registration are available at https://
tinyurl.com/SGMwkshp.
FOR FURTHER INFORMATION CONTACT:
Irene Avila, Ph.D., Assistant Director,
Sexual & Gender Minority Research
Office (SGMRO), avilai@mail.nih.gov,
301–594–9701.
SUPPLEMENTARY INFORMATION:
Background: ‘‘Sexual and gender
minority’’ is an umbrella term that
includes, but is not limited to,
individuals who identify as lesbian, gay,
bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex.
Individuals with same-sex or -gender
attractions or behaviors and those with
a difference in sex development are also
included. These populations also
encompass those who do not selfidentify with one of these terms but
whose sexual orientation, gender
identity or expression, or reproductive
development is characterized by nonbinary constructs of sexual orientation,
gender, and/or sex.
In accordance with Section 404N of
the 21st Century Cures Act (Pub. L. 114–
255), the Director of NIH shall
encourage research on SGM
populations. The Sexual and Gender
Minority Research Office (SGMRO)
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
F–SEP.
Date: October 25–26, 2021.
Time: 09:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–3398, dennis.hlasta@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: July 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16161 Filed 7–28–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
40863
coordinates SGM-related research and
activities by working directly with NIH
Institutes, Centers, and Offices. The
Office was officially established in
September 2015 within the Division of
Program Coordination, Planning, and
Strategic Initiatives (DPCPSI) in the NIH
Office of the Director and has the
following operational goals: (1) Advance
rigorous research on the health of SGM
populations in both the extramural and
intramural research communities; (2)
expand SGM health research by
fostering partnerships and
collaborations with a strategic array of
internal and external stakeholders; (3)
foster a highly skilled and diverse
workforce in SGM health research; and
(4) encourage data collection related to
SGM populations in research and the
biomedical research workforce. The
Scientific Workshop on Violence and
Related Health Outcomes in Sexual and
Gender Minority Communities
represents an important step in
pursuing these goals specifically in the
field of violence research.
The NIH Scientific Workshop on
Violence and Related Health Outcomes
in Sexual and Gender Minority
Communities Phase IV Public Meeting
Details
The NIH Scientific Workshop on
Violence and Related Health Outcomes
in Sexual and Gender Minority
Communities invites stakeholders
throughout the scientific research
community, clinical practice
communities, patient and family
advocates, scientific or professional
organizations, federal partners, internal
NIH stakeholders, and other interested
members of the public to participate and
provide comments, questions, or
feedback at the workshop. The goal of
the meeting is to identify opportunities
in violence-related research. Public
input will serve as a valuable element
in the development of the final
proposed research opportunities.
This notice serves as the
announcement for the fourth and final
phase of the Scientific Workshop on
Violence and Related Health Outcomes
in Sexual and Gender Minority
Communities. Phase I was the Request
for Information (RFI) https://
www.federalregister.gov/documents/
2020/11/25/2020-26094/request-forinformation-on-research-opportunitiesrelated-to-the-national-institutes-ofhealth published in November 2020.
The summary of the comments received
can be found on the https://
dpcpsi.nih.gov/sgmro website. Phase II
was a session on the state of the science
for violence research affecting SGM
communities (a recording will be
E:\FR\FM\29JYN1.SGM
29JYN1
40864
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
available after August 26, 2021). The
meeting applied an ecological model
focusing on family of origin abuse
across the lifespan, victimization by
peers and friends, romantic and sexual
partner violence, and community
violence. Phase III included working
groups to identify and describe research
opportunities to further understand the
role of violence in the health of SGM
individuals. The working groups were
comprised of these five domains:
• Demographics and Epidemiology
• Risk Factors and Pathways
• Preventive Interventions
• Treatment-focused Interventions
• Ethics and Logistical Challenges
Phase IV will involve moderated
discussions with the presenters from the
Phase III working groups to refine
research opportunities needed to further
our understanding of violence in SGM
communities. Audience feedback,
comments, and questions during this
session will help further refine the
proposed research opportunities.
Dated: July 21, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–16190 Filed 7–28–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Signaling
and Molecular Endocrinology.
Date: August 23, 2021.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
19:19 Jul 28, 2021
Jkt 253001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 23, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16112 Filed 7–28–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[CBP Dec. 21–12]
COBRA Fees To Be Adjusted for
Inflation in Fiscal Year 2022
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces
that U.S. Customs and Border Protection
(CBP) is adjusting certain customs user
fees and corresponding limitations
established by the Consolidated
Omnibus Budget Reconciliation Act
(COBRA) for Fiscal Year 2022 in
accordance with the Fixing America’s
Surface Transportation Act (FAST Act)
as implemented by the CBP regulations.
DATES: The adjusted amounts of
customs COBRA user fees and their
corresponding limitations set forth in
this notice for Fiscal Year 2022 are
required as of October 1, 2021.
FOR FURTHER INFORMATION CONTACT: Tina
Ghiladi, Senior Advisor, International
Travel & Trade, Office of Finance, 202–
344–3722, UserFeeNotices@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Contact Person: Latha Meenalochana
Malaiyandi, Ph.D. Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 812Q, Bethesda, MD 20892, (301) 435–
1999, malaiyandilm@csr.nih.gov.
I. Background
A. Adjustments of COBRA User Fees
and Corresponding Limitations for
Inflation
On December 4, 2015, the Fixing
America’s Surface Transportation Act
(FAST Act, Pub. L. 114–94) was signed
into law. Section 32201 of the FAST Act
amended section 13031 of the
Consolidated Omnibus Budget
Reconciliation Act (COBRA) of 1985 (19
U.S.C. 58c) by requiring the Secretary of
the Treasury (Secretary) to adjust certain
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
customs COBRA user fees and
corresponding limitations to reflect
certain increases in inflation.
Sections 24.22 and 24.23 of title 19 of
the Code of Federal Regulations (19 CFR
24.22 and 24.23) describe the
procedures that implement the
requirements of the FAST Act.
Specifically, paragraph (k) in § 24.22 (19
CFR 24.22(k)) sets forth the
methodology to determine the change in
inflation as well as the factor by which
the fees and limitations will be adjusted,
if necessary. The fees and limitations
subject to adjustment, which are set
forth in appendix A and appendix B of
part 24, include the commercial vessel
arrival fees, commercial truck arrival
fees, railroad car arrival fees, private
vessel arrival fees, private aircraft
arrival fees, commercial aircraft and
vessel passenger arrival fees, dutiable
mail fees, customs broker permit user
fees, barges and other bulk carriers
arrival fees, and merchandise processing
fees, as well as the corresponding
limitations.
B. Determination of Whether an
Adjustment Is Necessary for Fiscal Year
2022
In accordance with 19 CFR 24.22, CBP
must determine annually whether the
fees and limitations must be adjusted to
reflect inflation. For Fiscal Year 2022,
CBP is making this determination by
comparing the average of the Consumer
Price Index—All Urban Consumers, U.S.
All items, 1982–1984 (CPI–U) for the
current year (June 2020–May 2021) with
the average of the CPI–U for the
comparison year (June 2019–May 2020)
to determine the change in inflation, if
any. If there is an increase in the CPI–
U of greater than one (1) percent, CBP
must adjust the customs COBRA user
fees and corresponding limitations
using the methodology set forth in 19
CFR 24.22(k). Following the steps
provided in paragraph (k)(2) of § 24.22,
CBP has determined that the increase in
the CPI–U between the most recent June
to May twelve-month period (June
2020–May 2021) and the comparison
year (June 2019–May 2020) is 1.94 1
percent. As the increase in the CPI–U is
greater than one (1) percent, the customs
COBRA user fees and corresponding
limitations must be adjusted for Fiscal
Year 2022.
1 The figures provided in this notice may be
rounded for publication purposes only. The
calculations for the adjusted fees and limitations
were made using unrounded figures, unless
otherwise noted.
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40863-40864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
The National Institutes of Health (NIH) Scientific Workshop on
Violence & Related Health Outcomes in Sexual & Gender Minority
Communities Open Session
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) will hold the Phase IV
open session for the NIH Scientific Workshop on Violence and Related
Health Outcomes in Sexual and Gender Minority (SGM) Communities to
enhance our understanding of violence against SGM individuals and
identify opportunities in violence-related research. The primary
objectives of NIH's Phase IV meeting are: (1) To allow the public to
participate, and (2) to further refine research opportunities.
DATES: The NIH Scientific Workshop on Violence and Related Health
Outcomes in Sexual and Gender Minority Communities Phase IV virtual
meeting will be held on Thursday, August 26, 2021, from 12:00-4:00 p.m.
Eastern Daylight Time (New York, GMT).
ADDRESSES: The meeting will be held virtually via WebEx.
The preliminary agenda and registration are available at https://tinyurl.com/SGMwkshp.
FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant
Director, Sexual & Gender Minority Research Office (SGMRO),
[email protected], 301-594-9701.
SUPPLEMENTARY INFORMATION:
Background: ``Sexual and gender minority'' is an umbrella term that
includes, but is not limited to, individuals who identify as lesbian,
gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or
intersex. Individuals with same-sex or -gender attractions or behaviors
and those with a difference in sex development are also included. These
populations also encompass those who do not self-identify with one of
these terms but whose sexual orientation, gender identity or
expression, or reproductive development is characterized by non-binary
constructs of sexual orientation, gender, and/or sex.
In accordance with Section 404N of the 21st Century Cures Act (Pub.
L. 114-255), the Director of NIH shall encourage research on SGM
populations. The Sexual and Gender Minority Research Office (SGMRO)
coordinates SGM-related research and activities by working directly
with NIH Institutes, Centers, and Offices. The Office was officially
established in September 2015 within the Division of Program
Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH
Office of the Director and has the following operational goals: (1)
Advance rigorous research on the health of SGM populations in both the
extramural and intramural research communities; (2) expand SGM health
research by fostering partnerships and collaborations with a strategic
array of internal and external stakeholders; (3) foster a highly
skilled and diverse workforce in SGM health research; and (4) encourage
data collection related to SGM populations in research and the
biomedical research workforce. The Scientific Workshop on Violence and
Related Health Outcomes in Sexual and Gender Minority Communities
represents an important step in pursuing these goals specifically in
the field of violence research.
The NIH Scientific Workshop on Violence and Related Health Outcomes in
Sexual and Gender Minority Communities Phase IV Public Meeting Details
The NIH Scientific Workshop on Violence and Related Health Outcomes
in Sexual and Gender Minority Communities invites stakeholders
throughout the scientific research community, clinical practice
communities, patient and family advocates, scientific or professional
organizations, federal partners, internal NIH stakeholders, and other
interested members of the public to participate and provide comments,
questions, or feedback at the workshop. The goal of the meeting is to
identify opportunities in violence-related research. Public input will
serve as a valuable element in the development of the final proposed
research opportunities.
This notice serves as the announcement for the fourth and final
phase of the Scientific Workshop on Violence and Related Health
Outcomes in Sexual and Gender Minority Communities. Phase I was the
Request for Information (RFI) https://www.federalregister.gov/documents/2020/11/25/2020-26094/request-for-information-on-research-opportunities-related-to-the-national-institutes-of-health published in
November 2020. The summary of the comments received can be found on the
https://dpcpsi.nih.gov/sgmro website. Phase II was a session on the
state of the science for violence research affecting SGM communities (a
recording will be
[[Page 40864]]
available after August 26, 2021). The meeting applied an ecological
model focusing on family of origin abuse across the lifespan,
victimization by peers and friends, romantic and sexual partner
violence, and community violence. Phase III included working groups to
identify and describe research opportunities to further understand the
role of violence in the health of SGM individuals. The working groups
were comprised of these five domains:
Demographics and Epidemiology
Risk Factors and Pathways
Preventive Interventions
Treatment-focused Interventions
Ethics and Logistical Challenges
Phase IV will involve moderated discussions with the presenters
from the Phase III working groups to refine research opportunities
needed to further our understanding of violence in SGM communities.
Audience feedback, comments, and questions during this session will
help further refine the proposed research opportunities.
Dated: July 21, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-16190 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P
